13-05-2025 |
PM |
|
CAPR |
Capricor Therapeutics, Inc. |
289.59 |
-0.53 |
-0.33 |
-0.31 |
Capricor Therapeutics GAAP EPS of -$0.53 misses by $0.21 [5/14/2025 2:45 AM] |
7.71 |
0.41 (5.55%) |
7.68 |
0.38 (5.21%) |
3.52 - 23.40 |
3,888,458 |
3,670,000 |
25,698 |
|
|
19-03-2025 |
AH |
|
CAPR |
Capricor Therapeutics, Inc. |
601.57 |
-0.16 |
-0.31 |
-0.02 |
Capricor Therapeutics GAAP EPS of -$0.16 beats by $0.01, revenue of $11.13M beats by $1.26M [3/19/2025 4:07 PM] |
14.29 |
2.06 (16.90%) |
12.54 |
0.32 (2.62%) |
3.52 - 23.40 |
3,004,499 |
1,190,000 |
5,062 |
|
|
13-11-2024 |
AH |
|
CAPR |
Capricor Therapeutics, Inc. |
635.81 |
-0.38 |
-0.34 |
-0.25 |
Capricor Therapeutics GAAP EPS of -$0.38 misses by $0.02, revenue of $2.3M misses by $1.27M [11/13/2024 4:14 PM] |
18.52 |
1.61 (9.52%) |
17.14 |
0.23 (1.36%) |
2.80 - 23.40 |
1,725,382 |
1,040,000 |
5,743 |
|
|
07-08-2024 |
AH |
|
CAPR |
Capricor Therapeutics, Inc. |
123.75 |
-0.35 |
-0.31 |
-0.29 |
Capricor Therapeutics GAAP EPS of -$0.35 beats by $0.01, revenue of $3.97M beats by $0.31M [8/7/2024 4:17 PM] |
3.83 |
0.27 (7.72%) |
3.95 |
0.39 (10.96%) |
2.68 - 8.22 |
720,115 |
360,000 |
4,231 |
|
|
13-05-2024 |
AH |
|
CAPR |
Capricor Therapeutics, Inc. |
170.19 |
-0.31 |
-0.11 |
-0.31 |
Capricor Therapeutics GAAP EPS of -$0.31 misses by $0.20, revenue of $4.91M misses by $4.79M [5/13/2024 4:13 PM] |
5.22 |
-0.22 (-3.95%) |
5.06 |
-0.38 (-6.99%) |
2.68 - 8.22 |
625,964 |
210,000 |
20,471 |
|
|
29-02-2024 |
AH |
|
CAPR |
Capricor Therapeutics, Inc. |
121.94 |
-0.02 |
-0.23 |
-0.31 |
Capricor Therapeutics GAAP EPS of -$0.02 beats by $0.18, revenue of $12.08M beats by $1.48M [2/29/2024 4:16 PM] |
4.57 |
0.37 (8.81%) |
4.49 |
0.29 (6.90%) |
2.68 - 8.22 |
353,575 |
190,000 |
7,692 |
|
|
14-11-2023 |
AH |
|
CAPR |
Capricor Therapeutics, Inc. |
72.18 |
-0.25 |
-0.27 |
-0.26 |
Capricor Therapeutics GAAP EPS of -$0.25 beats by $0.05, revenue of $6.19M beats by $3.02M [11/14/2023 4:08 PM] |
3.19 |
0.19 (6.15%) |
3.01 |
0.0 (0.00%) |
2.68 - 8.22 |
225,280 |
200,000 |
7,595 |
|
|
07-08-2023 |
AH |
|
CAPR |
Capricor Therapeutics, Inc. |
112.20 |
-0.29 |
-0.34 |
-0.29 |
Capricor Therapeutics GAAP EPS of -$0.29 beats by $0.06, revenue of $3.92M beats by $2.32M [8/7/2023 4:32 PM] |
5.71 |
1.00 (21.23%) |
5.00 |
0.29 (6.16%) |
3.30 - 6.58 |
315,313 |
40,000 |
901 |
|
|
11-05-2023 |
AH |
4:00 PM ET (May 11) |
CAPR |
Capricor Therapeutics, Inc. |
101.84 |
-0.31 |
-0.32 |
-0.32 |
Capricor Therapeutics GAAP EPS of -$0.31 beats by $0.01, revenue of $2.98M beats by $2.48M [5/11/2023 4:03 PM] |
4.06 |
-0.05 (-1.22%) |
4.20 |
0.09 (2.24%) |
2.81 - 6.58 |
61,431 |
50,000 |
642 |
|
|
15-03-2023 |
AH |
4:00 PM ET (Mar 15) |
CAPR |
Capricor Therapeutics, Inc. |
108.54 |
-0.31 |
0.00 |
-0.26 |
Capricor Therapeutics GAAP EPS of -$0.31 beats by $0.03, revenue of $0.96M beats by $0.96M [3/15/2023 4:03 PM] |
4.52 |
0.05 (1.12%) |
4.64 |
0.17 (3.80%) |
2.81 - 6.58 |
135,016 |
90,000 |
1,122 |
|
|
10-11-2022 |
AH |
4:05 PM ET (Nov 10) |
CAPR |
Capricor Therapeutics, Inc. |
119.05 |
-0.26 |
-0.28 |
-0.17 |
Capricor Therapeutics GAAP EPS of -$0.26 beats by $0.05, revenue of $1.59M beats by $1.45M [11/10/2022 4:03 PM] |
4.55 |
-0.35 (-7.14%) |
4.90 |
0.0 (0.00%) |
2.56 - 6.58 |
200,402 |
140,000 |
175 |
|
|
10-08-2022 |
AH |
4:00 PM ET (Aug 10) |
CAPR |
Capricor Therapeutics, Inc. |
108.00 |
-0.29 |
-0.25 |
-0.21 |
Capricor Therapeutics GAAP EPS of -$0.29 misses by $0.03 [8/10/2022 4:14 PM] |
5.30 |
0.78 (17.26%) |
4.70 |
0.18 (3.98%) |
2.56 - 5.85 |
546,716 |
100,000 |
12,816 |
|
|
10-05-2022 |
AH |
4:00 PM ET (May 10) |
CAPR |
Capricor Therapeutics, Inc. |
84.89 |
-0.32 |
0.00 |
-0.23 |
Capricor Therapeutics GAAP EPS of -$0.32 [5/10/2022 4:06 PM] |
2.91 |
-0.32 (-9.95%) |
3.18 |
0.06 (1.92%) |
2.56 - 6.22 |
107,902 |
90,000 |
120 |
|
|
10-03-2022 |
AH |
4:05 PM ET (Mar 10) |
CAPR |
Capricor Therapeutics, Inc. |
106.98 |
-0.26 |
-0.19 |
-0.21 |
|
4.22 |
0.10 (2.43%) |
4.24 |
0.12 (2.91%) |
2.56 - 6.22 |
166,951 |
180,000 |
4,058 |
|
|
09-11-2021 |
AH |
4:00 PM ET (Nov 9) |
CAPR |
Capricor Therapeutics, Inc. |
87.71 |
-0.17 |
-0.22 |
-0.20 |
Capricor Therapeutics EPS beats by $0.06 [11/9/2021 4:09 PM] |
3.50 |
-0.12 (-3.31%) |
3.62 |
0.0 (0.00%) |
3.13 - 8.40 |
257,395 |
160,000 |
4,734 |
|
|
12-08-2021 |
AH |
4:05 PM ET (Aug 12) |
CAPR |
Capricor Therapeutics, Inc. |
102.04 |
-0.21 |
-0.23 |
-0.23 |
Capricor Therapeutics EPS beats by $0.02, misses on revenue [8/12/2021 4:13 PM] |
4.03 |
-0.44 (-9.93%) |
4.08 |
-0.40 (-8.93%) |
3.13 - 8.40 |
411,531 |
110,000 |
32,880 |
|
|
13-05-2021 |
AH |
4:00 PM ET (May 13) |
CAPR |
Capricor Therapeutics, Inc. |
80.48 |
-0.23 |
0.00 |
-0.30 |
Capricor Therapeutics reports Q1 results [5/13/2021 4:21 PM] |
3.64 |
0.48 (15.19%) |
3.35 |
0.19 (6.01%) |
3.13 - 12.32 |
620,944 |
520,000 |
2,699 |
|
|
11-03-2021 |
AH |
4:00 PM ET (Mar 11) |
CAPR |
Capricor Therapeutics, Inc. |
105.30 |
-0.21 |
0.00 |
-0.34 |
Capricor Therapeutics EPS misses by $0.01 [3/11/2021 4:04 PM] |
5.18 |
-0.36 (-6.59%) |
4.88 |
-0.66 (-11.91%) |
0.88 - 12.32 |
504,669 |
423,807 |
22,425 |
|
|
12-11-2020 |
AH |
4:00 PM ET (Nov 12) |
CAPR |
Capricor Therapeutics, Inc. |
83.43 |
-0.20 |
0.00 |
-0.43 |
Capricor Therapeutics reports Q3 results [11/12/2020 4:07 PM] |
4.34 |
-0.30 (-6.56%) |
4.22 |
-0.43 (-9.25%) |
0.88 - 12.32 |
400,311 |
711,590 |
6,045 |
|
|
06-08-2020 |
AH |
4:00 PM ET (Aug 6) |
CAPR |
Capricor Therapeutics, Inc. |
109.55 |
-0.23 |
-0.37 |
-0.59 |
Capricor Therapeutics EPS beats by $0.11 [8/6/2020 4:05 PM] |
6.48 |
-1.42 (-17.97%) |
6.49 |
-1.41 (-17.85%) |
0.88 - 12.32 |
3,732,419 |
8,324,786 |
215,305 |
|
|